| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |